Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2009172.pdf
Reference104 articles.
1. Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F et al. (2007). Integrated profiling of basal and luminal breast cancers. Cancer Res 67: 11565–11575.
2. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI . (2004). Growth patterns and the risk of breast cancer in women. N Engl J Med 351: 1619–1626.
3. Allen GW, Saba C, Armstrong EA, Huang SM, Benavente S, Ludwig DL et al. (2007). Insulin-like growth factor-I receptor signaling blockade combined with radiation. Cancer Res 67: 1155–1162.
4. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull Jr FC, Allred DC et al. (1989). Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84: 1418–1423.
5. Attard G, Fong PC, Molife R, Reade S, Shaw H, Reid A et al. (2006). Phase I trial involving the pharmacodynamic (PD) study of circulating tumour cells, of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), with docetaxel (D) in patients (p) with advanced cancer. J Clin Oncol 24: 126s.
Cited by 245 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials;Ophthalmology;2024-07
2. Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition;iScience;2024-05
3. Fibrocyte Participation in Thyroid-Associated Ophthalmopathy Suggests New Approaches to Therapy;Ophthalmic Plastic & Reconstructive Surgery;2023-12
4. The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities;International Journal of Molecular Sciences;2023-10-04
5. Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors;JAMA Network Open;2023-07-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3